Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Aug 24, 2022
Open Peer Review Period: Aug 24, 2022 - Jul 27, 2023
Date Accepted: Jul 27, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Evaluating the Usability of Electronic Patient-Reported Outcome Apps: Comment on a Symptom Management Platform for Outpatients With Advanced Cancer

Haniuda Y, Tsubaki M, Ito Y

Evaluating the Usability of Electronic Patient-Reported Outcome Apps: Comment on a Symptom Management Platform for Outpatients With Advanced Cancer

JMIR Form Res 2023;7:e42153

DOI: 10.2196/42153

PMID: 37548992

PMCID: 10442726

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Response to “Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study”

  • Yu Haniuda; 
  • Michihiro Tsubaki; 
  • Yoshiyasu Ito

 


 Citation

Please cite as:

Haniuda Y, Tsubaki M, Ito Y

Evaluating the Usability of Electronic Patient-Reported Outcome Apps: Comment on a Symptom Management Platform for Outpatients With Advanced Cancer

JMIR Form Res 2023;7:e42153

DOI: 10.2196/42153

PMID: 37548992

PMCID: 10442726

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.